can i take glp 1 for only 3 months Weight Loss Injections — MesoHealth GLP-1 Medications for Weight Loss:

Patents behind Ozempic, and other weight-loss drugs Behind Novo Nordisks weight-loss drugs, such as Ozempic and Wegovy, is a growing portfolio of patents covering semaglutide formulations, delivery methods, and dosing strategies

The 2025 dip likely reflects a combination of maturity and segmentation: fewer new injectable entrants are needed once the market is saturated with credible programs, while attention partially rotates toward oral strategies and next-gen incretin biology

An overview of once-weekly glucagon-like peptide-1 receptor agonistsAvailable efficacy and safety data and perspectives for the future

Go AS, Chertow GM, Fan D, et al

Questions to Ask Yourself Before choosing any GLP-1 telehealth program, consider these questions

You will typically need to demonstrate weight loss progress (usually at least 5% of starting body weight) for continued coverage